Art
J-GLOBAL ID:202002225313249616   Reference number:20A0368471

Evaluation of osimertinib efficacy according to BSA and BMI in patients with NSCLC harboring an EGFR mutation

EGFR変異を伴うNSCLC患者におけるBSAおよびBMIに応じたオシメルチニブ有効性の評価
Author (9):
Material:
Volume: 17th  Page: ROMBUNNO.P3-065  Publication year: 2019 
JST Material Number: L7804B  Document type: Proceedings
Article type: 会議録記事  Country of issue: Japan (JPN)  Language: ENGLISH (EN)
Body text partially displayed:
Body text partially displayed
The beginning part of either the article's body or abstract is displayed (up to about 100 characters).
On JDreamⅢ (charged service), you can see this item immediately after the record is posted.
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addition, medical articles require to login to MyJ-GLOBAL.
...[Body text partially displayed]
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0368471&from=J-GLOBAL&jstjournalNo=L7804B") }}
JST classification (3):
JST classification
Category name(code) classified by JST.
Tumors(=neoplasms)of respiratory system  ,  Drug therapy(=pharmacotherapy)for tumors  ,  Genetic variation 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.

Return to Previous Page